Apolipoprotein C2 Test

Apolipoprotein C2, often abbreviated as APOC2, is a small protein found in the bloodstream that plays a central role in how we process fats. It attaches to particles called lipoproteins, which are responsible for transporting fats and cholesterol throughout the body. APOC2’s key job is to activate an enzyme known as lipoprotein lipase. This enzyme breaks down triglycerides, fats that circulate in the blood after meals, into free fatty acids that can be used for energy or stored in tissues. Without APOC2, this fat-clearing process does not work efficiently.

When APOC2 is not functioning properly, triglycerides build up in the blood, leading to a condition called hypertriglyceridemia. Persistently high triglycerides are linked to inflammation of the pancreas (pancreatitis) and contribute to the development of atherosclerosis, the buildup of fatty plaques in arteries that can lead to heart attacks and strokes. Even subtle genetic variations in the APOC2 gene can affect how well someone clears fats, influencing their long-term cardiovascular risk.

Beyond its role in lipid metabolism, APOC2 is drawing attention for its involvement in cancer biology. In acute myeloid leukemia (AML), a type of blood cancer, APOC2 is found in unusually high amounts and seems to drive leukemia growth by interacting with other proteins on cell surfaces. In pancreatic cancer, elevated levels of APOC2 in the blood are associated with worse survival, making it a potential marker for disease severity. Researchers are now exploring whether targeting APOC2 or its pathways could open new treatment strategies for these cancers.